lobbying_activities
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
1,364 rows where filing_year = 2022 and issue_code = "MED" sorted by filing_year descending
This data as json, CSV (advanced)
Suggested facets: filing_type, is_termination, received_date (date)
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year ▲ | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2769087 | O'NEILL AND ASSOCIATES 90808ceb-73b6-4ab4-8cc8-bbf5a9805b19 | 1T | O'NEILL AND ASSOCIATES | 73134 | ANALOGIC | 2022 | first_quarter | MED | medical technology | HOUSE OF REPRESENTATIVES,SENATE | 5500 | 0 | 1 | 2022-02-07T08:52:37.947000-05:00 | |
| 2769373 | FRANCIS EDWARD & CRONIN, INC. 75a5dcf9-bbed-44b6-a6a0-dd4596c8a13a | Q1 | FRANCIS EDWARD & CRONIN, INC. | 311314 | CURE ALZHEIMER'S FUND | 2022 | first_quarter | MED | Issues and legislation related to Alzheimer's disease research | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE | 20000 | 0 | 0 | 2022-04-01T08:52:55-04:00 | |
| 2769374 | FRANCIS EDWARD & CRONIN, INC. d17c312b-bbc8-446d-93b0-80836f2aad90 | Q1 | FRANCIS EDWARD & CRONIN, INC. | 311314 | PATH DECISION SUPPORT SOFTWARE, LLC | 2022 | first_quarter | MED | Issues and legislation related to diabetes treatment and diagnosis | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Natl Science Foundation (NSF),SENATE,Veterans Affairs, Dept of (VA) | 0 | 0 | 2022-04-01T08:54:58-04:00 | ||
| 2769586 | MARSHALL BRACHMAN ad808937-b025-4e19-acb6-3bea610b31ba | Q1 | MARSHALL BRACHMAN | 6848 | BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM | 2022 | first_quarter | MED | support funding for medical research programs | HOUSE OF REPRESENTATIVES,SENATE | 33000 | 0 | 0 | 2022-04-03T14:43:25-04:00 | |
| 2769609 | RAY C CULVER III 260cdd44-3582-4946-9382-f2c8321cb11a | Q1 | RAY C CULVER III | 11468 | ARKANSAS CHILDREN'S HOSPITAL | 2022 | first_quarter | MED | FY2022 Consolidated Appropriations Act, Division A funding for USDA ARS human nutrition research centers | HOUSE OF REPRESENTATIVES,SENATE | 5000 | 0 | 0 | 2022-04-03T21:03:54-04:00 | |
| 2769610 | RAY C CULVER III 220a0d91-861a-4c0e-a734-404e4662860d | 1A | RAY C CULVER III | 11468 | ARKANSAS CHILDREN'S HOSPITAL | 2022 | first_quarter | MED | FY2022 Consolidated Appropriations Act, Division A funding for USDA ARS human nutrition research centers | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2022-04-03T21:12:43-04:00 | |
| 2769718 | MAGILL ASSOCIATES, LLC bbf60b9e-4de3-44a7-81f2-6d24bba19911 | Q1 | MAGILL ASSOCIATES, LLC | 401103511 | THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES | 2022 | first_quarter | MED | H.R. 2471 - Consolidated Appropriations Act, 2022 FY 2022 appropriations for the development of a synthetic vaccine | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2022-04-04T11:30:35-04:00 | |
| 2769846 | AMERICAN COLLEGE OF CLINICAL PHARMACY 7fe58b10-f35c-499a-83fb-6cd4c6644efa | Q1 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 57258 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 2022 | first_quarter | MED | Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 144981 | 0 | 0 | 2022-04-04T17:45:12-04:00 | |
| 2769936 | AUBURN HEALTH STRATEGIES, LLC a11f5afe-a893-4f7b-a196-1783d39fcac7 | Q1 | AUBURN HEALTH STRATEGIES, LLC | 292697 | AMERICAN PROFICIENCY INSTITUTE | 2022 | first_quarter | MED | Proficiency testing for clinical laboratories | Health & Human Services, Dept of (HHS) | 0 | 0 | 2022-04-05T11:23:25-04:00 | ||
| 2769937 | AUBURN HEALTH STRATEGIES, LLC f77c3a10-3843-443d-925c-b1f3fcfa9877 | Q1 | AUBURN HEALTH STRATEGIES, LLC | 292697 | AMERICAN PROFICIENCY INSTITUTE | 2022 | first_quarter | MED | Proficiency testing for clinical laboratories | Health & Human Services, Dept of (HHS) | 0 | 0 | 2022-04-05T11:23:36-04:00 | ||
| 2769974 | MUSCULAR DYSTROPHY ASSOCIATION, INC. 9b17da81-b39a-4ef7-8ae6-23a961f4245d | Q1 | MUSCULAR DYSTROPHY ASSOCIATION, INC. | 400348610 | MUSCULAR DYSTROPHY ASSOCIATION, INC. | 2022 | first_quarter | MED | Advocated in favor of robust appropriations funding for the National Institutes of Health, the Food and Drug Administration, the Health Resources and Services Administration, and the Centers for Disease Control and Prevention. Advocated for greater appropriations for the National Center for Advancing Translational Sciences (NCATS) Advocated for greater appropriations for the National Institutes of Health. Advocated for appropriations for HHS, NIH, and FDA to implement the ACT for ALS. Provided feedback and comments to the Senate's PREVENT Act. | Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 100000 | 0 | 0 | 2022-04-05T14:19:01-04:00 | |
| 2770152 | COVINGTON & BURLING LLP 3fbe6b76-fdd1-412a-8fe7-35eca3640643 | Q1 | COVINGTON & BURLING LLP | 11195 | SL 2T, LLC ("SMARTLABS") | 2022 | first_quarter | MED | Education and support for policies and funding to advance turnkey, co-located, on-demand pharma grade research laboratory environments, including relating to the PREVENT Pandemics Act (S. 3799) and the ARPA-H Act (H.R. 5585). | HOUSE OF REPRESENTATIVES,SENATE | 90000 | 0 | 0 | 2022-04-06T13:47:17-04:00 | |
| 2770204 | AMERICAN GASTROENTEROLOGICAL ASSOCIATION ba8c9559-6fcd-45b0-97df-dd8672079173 | Q1 | AMERICAN GASTROENTEROLOGICAL ASSOCIATION | 59650 | AMERICAN GASTROENTEROLOGICAL ASSOCIATION | 2022 | first_quarter | MED | Lobbied in support of increased federal research funding for the NIH, VA, and DoD's Congressionally Directly Medical Research Program. Lobbied in support of H.R. 289/H.R. 869, the RISE Act, to provide $25 billion in research funding to research facilities whose research was disrupted due to the COVID-19 pandemic. | HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2022-04-06T15:57:05-04:00 | |
| 2770262 | THE HARRIS FIRM 78e4f507-001e-4a04-a139-7dbc4899863f | Q1 | THE HARRIS FIRM | 68376 | HOLISTIC INDUSTRIES INC. | 2022 | first_quarter | MED | Issues pertaining to cannabis CSA scheduling. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2022-04-06T19:10:35-04:00 | |
| 2770477 | MARSHFIELD CLINIC HEALTH SYSTEM 66264752-4b68-429b-9cc6-8a3ab9643d6e | Q1 | MARSHFIELD CLINIC HEALTH SYSTEM | 57830 | MARSHFIELD CLINIC HEALTH SYSTEM | 2022 | first_quarter | MED | COVID-19, agricultural occupational health, NIOSH | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2022-04-07T23:30:10-04:00 | |
| 2770649 | PROTON THERAPY CONSORTIUM FKA NATIONAL ASSOCIATION FOR PROTON THERAPY c623570e-ef8f-4ef2-9d1e-479d8fc19102 | Q1 | PROTON THERAPY CONSORTIUM FKA NATIONAL ASSOCIATION FOR PROTON THERAPY | 401106232 | PROTON THERAPY CONSORTIUM FKA NATIONAL ASSOCIATION FOR PROTON THERAPY | 2022 | first_quarter | MED | Commercial insurance coverage for radiation oncology; Physician fee schedule; HOPPS 2022; RO APM Model; Medicare & Medicaid coverage for radiation oncology; proton therapy | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2022-04-08T11:04:14-04:00 | ||
| 2770710 | MCDERMOTT+ LLC 1887485a-ee75-42e8-87c1-2d54252dc26e | Q1 | MCDERMOTT+ LLC | 401103287 | COALITION FOR 21ST CENTURY MEDICINE | 2022 | first_quarter | MED | Issues concerning regulation of laboratory-developed tests. | Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 40000 | 0 | 0 | 2022-04-08T12:42:47-04:00 | |
| 2770980 | THE PETRIZZO GROUP, INC. e89c9a1f-94c5-4a70-b6f7-d9fee978efd8 | Q1 | THE PETRIZZO GROUP, INC. | 305932 | ALLEN INSTITUTE | 2022 | first_quarter | MED | Advancing initiatives to fund research of the immune system in underserved and understudied population communities to detect and prevent a downward spiral of vulnerable patients in this pandemic and future pandemics. Advocating for funding of research to develop a specialized suite of ethnically diverse and tissue-specific cell lines with accessible, stable, and reproducible human cell lines that are representative of our diverse population. | HOUSE OF REPRESENTATIVES,SENATE | 45000 | 0 | 0 | 2022-04-09T16:41:56-04:00 | |
| 2770984 | THE PETRIZZO GROUP, INC. 99a7affa-aa4a-4732-bc5c-9bcd7a8053ea | Q1 | THE PETRIZZO GROUP, INC. | 305932 | IBIO, INC. | 2022 | first_quarter | MED | Advance iBio as the leader in plant-made pharmaceutical manufacturing and collaboration between the U.S. Government for research and development of domestic advanced vaccine manufacturing platforms. COVID-19 pandemic preparedness. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2022-04-09T16:47:54-04:00 | |
| 2770986 | THE PETRIZZO GROUP, INC. 648e7da4-f02d-4479-b162-227b22a75f8d | Q1 | THE PETRIZZO GROUP, INC. | 305932 | IMMUNITYBIO, INC. | 2022 | first_quarter | MED | Federal support for next generation COVID-19 vaccine technology research, development and manufacturing, approval and distribution. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office | 60000 | 0 | 0 | 2022-04-09T16:52:57-04:00 | |
| 2771115 | THE PETRIZZO GROUP, INC. 5e0b702a-eb36-4afe-9010-01b34ec91193 | Q1 | THE PETRIZZO GROUP, INC. | 305932 | ACCESS TO ADVANCED HEALTH INSTITUTE | 2022 | first_quarter | MED | Advocating for funding for COVID-19 vaccine and therapy development and manufacturing; funding for flu vaccine, support adjuvant inclusion in COVID-19 countermeasures. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 45000 | 0 | 0 | 2022-04-10T12:06:10-04:00 | |
| 2771122 | THE PETRIZZO GROUP, INC. c77910c4-9f82-49a8-b1b6-36e46cfa6a60 | Q1 | THE PETRIZZO GROUP, INC. | 305932 | SEATTLE CHILDREN'S HOSPITAL RESEARCH AND FOUNDATION | 2022 | first_quarter | MED | Pediatricians Accelerate Childhood Therapies Act of 2021 Increased NIH funding for pediatric research | HOUSE OF REPRESENTATIVES,SENATE | 45000 | 0 | 0 | 2022-04-10T12:12:39-04:00 | |
| 2771130 | THE PETRIZZO GROUP, INC. b483e22a-0a69-4784-930a-4284468eb0e1 | Q1 | THE PETRIZZO GROUP, INC. | 305932 | OMEROS CORPORATION | 2022 | first_quarter | MED | Advocated for Medicare Part B packaged payment reforms; and the expansion of the non-opioid pain management drug exclusion to the drugs functioning as supplies during a surgical procedure packaging policy. NO PAIN Act | HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2022-04-10T12:17:48-04:00 | |
| 2771202 | THE CONSILIO GROUP e978ff25-24f9-48fa-a143-ffb4edad5471 | Q1 | THE CONSILIO GROUP | 400374717 | DETECTACHEM | 2022 | first_quarter | MED | Chemical detection test for COVID-19 | Air Force, Dept of,Defense, Dept of (DOD),Education, Dept of,Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Navy, Dept of,SENATE,White House Office | 16500 | 0 | 0 | 2022-04-11T09:30:33-04:00 | |
| 2771403 | UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 60725d83-6bfd-4491-91ce-62d423573cba | Q1 | UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 89235 | UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2022 | first_quarter | MED | Issues related to pandemic preparedness. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 35000 | 0 | 0 | 2022-04-11T12:01:56-04:00 | |
| 2771537 | THE PRENDA GROUP LLC aafff3d0-cbb1-43af-a843-cd76d0987f0b | Q1 | THE PRENDA GROUP LLC | 401104543 | UV-CONCEPTS | 2022 | first_quarter | MED | Emergency response to COVID-19 Pandemic. Assistance to Hospitals / Veterans Administration Facilities / First Responders / Medical facilities etc. for patients, visitors, and healthcare workers. ULTRAVIOLET LIGHT ENCLOSURE TECHNOLOGY FOR BROAD APPLICATIONS IN HEALTHCARE AND NON-HEALTHCARE SECTORS. Monitoring COVID-19 Stimulus Packages and appropriations. Coronavirus Response and Relief | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2022-04-11T14:00:43-04:00 | ||
| 2771541 | THE PRENDA GROUP LLC b0932b2f-9e3a-4b5a-ae24-f3aa2b8be4fe | Q1 | THE PRENDA GROUP LLC | 401104543 | UV-CONCEPTS | 2022 | first_quarter | MED | Emergency response to COVID-19 Pandemic. Assistance to Hospitals / Veterans Administration Facilities / First Responders / Medical facilities etc. for patients, visitors, and healthcare workers. ULTRAVIOLET LIGHT ENCLOSURE TECHNOLOGY FOR BROAD APPLICATIONS IN HEALTHCARE AND NON-HEALTHCARE SECTORS. Monitoring COVID-19 Stimulus Packages and appropriations. Coronavirus Response and Relief | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2022-04-11T14:01:02-04:00 | ||
| 2771690 | THE CJR GROUP, INC. d4bb5597-edcf-4786-8446-60bfe48f8e55 | Q1 | THE CJR GROUP, INC. | 288293 | UNIVERSITY HOSPITALS HEALTH SYSTEM | 2022 | first_quarter | MED | Issues related to COVID-19 and funding for hospitals | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2022-04-11T19:19:52-04:00 | |
| 2771947 | MICHIGAN TECHNOLOGICAL UNIVERSITY 5d537083-8aa4-4434-a4ca-ac63d655de20 | Q1 | MICHIGAN TECHNOLOGICAL UNIVERSITY | 25181 | MICHIGAN TECHNOLOGICAL UNIVERSITY | 2022 | first_quarter | MED | Discussed issues of interest related to higher education for the COVID-19 pandemic. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2022-04-12T11:09:04-04:00 | |
| 2772025 | CHAMBER HILL STRATEGIES 48621ffe-5dcb-4a0e-919c-0c27093dd355 | Q1 | CHAMBER HILL STRATEGIES | 400645947 | SANFORD HEALTH | 2022 | first_quarter | MED | H.R. 6000, Cures 2.0 Act. | HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2022-04-12T11:53:05-04:00 | |
| 2772319 | RELX INC. 88f3029e-991b-401b-bf08-5d9766b6a817 | Q1 | RELX INC. | 49511 | RELX INC | 2022 | first_quarter | MED | Issues related to US-UK Cancer Summit and Cancer Moonshot initiative. Issues related to NIHs diversity, equity, inclusion and accessibility efforts. | Health & Human Services, Dept of (HHS) | 520000 | 0 | 0 | 2022-04-12T15:51:20-04:00 | |
| 2772438 | BOSE PUBLIC AFFAIRS GROUP 50484d2d-bcab-4921-8930-76ce1e21ba86 | Q1 | BOSE PUBLIC AFFAIRS GROUP | 297294 | AMERICAN ACADEMY OF ANESTHESIOLOGIST ASSISTANTS | 2022 | first_quarter | MED | issues related to licensure | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) | 10000 | 0 | 0 | 2022-04-12T16:57:31-04:00 | |
| 2772519 | FEDERAL SOLUTIONS, LLC 189df676-cbb9-4fd3-9b85-471860d8f9a4 | Q1 | FEDERAL SOLUTIONS, LLC | 311371 | MISSISSIPPI STATE UNIVERSITY | 2022 | first_quarter | MED | Labor/HHS/Education Appropriations: Provisions relating to disease research | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2022-04-12T18:39:48-04:00 | |
| 2772621 | EFB ADVOCACY, LLC b5eede66-8a3c-4d71-b0a3-ae58fb2a848b | Q1 | EFB ADVOCACY, LLC | 401104430 | UNITED FOR MEDICAL RESEARCH | 2022 | first_quarter | MED | Funding Issues Related to the National Institutes of Health | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2022-04-13T09:46:07-04:00 | |
| 2772752 | BEN BARNES GROUP LP 8b9fe306-d1d4-47a1-aba2-72a7d3cb4842 | Q1 | BEN BARNES GROUP LP | 5415 | HUNTSMAN CORPORATION | 2022 | first_quarter | MED | CMS Medicare | HOUSE OF REPRESENTATIVES,SENATE | 18750 | 0 | 0 | 2022-04-13T11:07:06-04:00 | |
| 2772760 | BEN BARNES GROUP LP ce469cf3-8885-455c-bef2-5c6416ba23c7 | Q1 | BEN BARNES GROUP LP | 5415 | ENVIGO RMS LLC | 2022 | first_quarter | MED | Medical/Disease Research | HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 0 | 2022-04-13T11:13:11-04:00 | |
| 2772816 | IMPACT MANAGEMENT GROUP a7bf36d3-c158-4a0b-912b-28a6b499549c | Q1 | IMPACT MANAGEMENT GROUP | 401104137 | ARKANSAS RESEARCH ALLIANCE | 2022 | first_quarter | MED | On behalf of client support continued and future funding for clinical research programs in Arkansas | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2022-04-13T11:54:45-04:00 | ||
| 2773008 | ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 83cc059c-dfb7-4073-83c3-28bdc0038e91 | Q1 | ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) | 1466 | ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) | 2022 | first_quarter | MED | AACC joined with other healthcare groups in writing to the Senate HELP leadership endorsing S.3534, the Tracking Pathogens Act, which would support and enhance existing genomic sequencing and surveillance activities. AACC met with House and Senate staff urging that the Verifying Accurate Leading-edge IVCT Development (VALID) Act not be included in the Medical Device User Fee Amendments V legislative package that will be considered by Congress. AACC provided input to the Senate HELP committee on its draft "Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act," which would rebuild and strengthen our nations public health infrastructure. | HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2022-04-13T14:50:02-04:00 | |
| 2773101 | AMERICAN ASSOCIATION FOR CANCER RESEARCH 56e4c60d-4020-49fa-b2b1-3bc3ee9a5ac5 | Q1 | AMERICAN ASSOCIATION FOR CANCER RESEARCH | 400601833 | AMERICAN ASSOCIATION FOR CANCER RESEARCH | 2022 | first_quarter | MED | Cancer research Oncology product review at the FDA Pediatric research and cancer care Clinical trials Diversity in clinical trials | HOUSE OF REPRESENTATIVES,SENATE | 100000 | 0 | 0 | 2022-04-13T15:57:46-04:00 | |
| 2773370 | MCHUGH LEMAY ASSOC., LLC c50088e4-72bc-4015-b3b2-2f381eff6512 | Q1 | MCHUGH LEMAY ASSOC., LLC | 401105253 | CLARK STREET ASSOCIATES LLC ON BEHALF OF QORVO | 2022 | first_quarter | MED | Issues related to COVID testing - including the National Defense Authorization Act of 2023 (Not yet introduced). | Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 100000 | 0 | 0 | 2022-04-13T18:34:11-04:00 | |
| 2773422 | NATURAL RESOURCE RESULTS LLC d5e5a30c-ed87-4bdc-9920-f42818a8f2f9 | Q1 | NATURAL RESOURCE RESULTS LLC | 321555 | SHINE MEDICAL TECHNOLOGIES | 2022 | first_quarter | MED | Support funding at DOE for fusion technology development. | SENATE | 30000 | 0 | 0 | 2022-04-13T20:18:29-04:00 | |
| 2773444 | BRAMER GROUP LLC 42498bda-5e65-4ac4-a665-baa5c85bbd36 | Q1 | BRAMER GROUP LLC | 401103355 | TACTICAL MEDICAL SOLUTIONS, LLC | 2022 | first_quarter | MED | Medical Training, FY 2022 NDAA | Army, Dept of (Other),Defense, Dept of (DOD) | 8250 | 0 | 0 | 2022-04-13T20:45:37-04:00 | |
| 2773507 | HELIX, INC. 21a144d7-d22e-4ae9-8419-e0895dcbdc4c | Q1 | HELIX, INC. | 401106164 | HELIX, INC. | 2022 | first_quarter | MED | genomic research and testing, COVID-19 testing and research | Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 36520 | 0 | 0 | 2022-04-14T09:04:20-04:00 | |
| 2773510 | DREXEL UNIVERSITY 6f845dbf-cca2-4e9f-b1d2-f630c04f6272 | Q1 | DREXEL UNIVERSITY | 40032273 | DREXEL UNIVERSITY | 2022 | first_quarter | MED | Research, education and other matters related to higher ed. | HOUSE OF REPRESENTATIVES,SENATE | 81000 | 0 | 0 | 2022-04-14T09:04:54-04:00 | |
| 2773515 | DREXEL UNIVERSITY 32cc3bd0-c464-4c51-8a4d-23f490dc7bb6 | Q1 | DREXEL UNIVERSITY | 40032273 | ST. CHRISTOPHER'S HOSPITAL FOR CHILDREN | 2022 | first_quarter | MED | Children's health and welfare | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2022-04-14T09:09:07-04:00 | ||
| 2773821 | 60 PLUS ASSOCIATION dc8372e7-e8b4-4002-946b-995e968f2dd1 | Q1 | 60 PLUS ASSOCIATION | 41988 | 60 PLUS ASSOCIATION | 2022 | first_quarter | MED | Support legislation that would revamp laboratory data reporting requirements under the Protecting Access to Medicare Act (PAMA). | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2022-04-14T12:13:30-04:00 | ||
| 2774250 | FAMILIES USA FOUNDATION, INC. e3fd2cc6-bb36-42b4-9ed8-a98fceb056cf | Q1 | FAMILIES USA FOUNDATION, INC. | 14108 | FAMILIES USA FOUNDATION INC | 2022 | first_quarter | MED | S.1644Promising Pathway ActTo amend the Federal Food, Drug, and CosmeticActto establish a time-limited provisional approvalpathway, subject to specific obligations, for certain drugs and biological products, and for other purposes. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2022-04-14T14:36:36-04:00 | |
| 2774329 | HACKENSACK MERIDIAN HEALTH dcdfdce2-0e2d-4300-a85d-a9ab7c0c11cd | Q1 | HACKENSACK MERIDIAN HEALTH | 401104109 | HACKENSACK MERIDIAN HEALTH | 2022 | first_quarter | MED | National Institutes of Health funding Biomedical research and the creation of ARPA-H Support for the Center for Discovery and Innovation | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 160000 | 0 | 0 | 2022-04-14T15:25:22-04:00 | |
| 2774350 | DESIMONE CONSULTING, LLC 0842717a-c2e0-4289-8549-5c05d43cb39d | Q1 | DESIMONE CONSULTING, LLC | 400931695 | WE WORK FOR HEALTH | 2022 | first_quarter | MED | Issues related to access to medicines and other medical therapies, the development of new medical therapies, pharmaceutical supply chain and regulatory matters regarding the biopharmaceutical industry; PDUFA Reauthorization; FY2022 Budget Reconciliation (H.R.5376). | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2022-04-14T15:36:00-04:00 | |
| 2774415 | HAWLEY LLC f1d74385-df3a-4c26-837c-e0f8cad5522f | Q1 | HAWLEY LLC | 401105460 | MLA ASSOCIATES ON BEHALF OF CLARK STREET ASSOCIATES LLC ON BEHALF OF QORVO | 2022 | first_quarter | MED | Issues related to pathogen testing for COVID 19 and other diseases, including the not yet introduced National Defense Authorization Act for FY2023 | Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2022-04-14T15:54:14-04:00 | |
| 2774638 | GOVERNMENT COUNSEL, LLC 386312be-17a8-4aba-a832-d5e0a2f9d1cd | Q1 | GOVERNMENT COUNSEL, LLC | 401105070 | HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS) | 2022 | first_quarter | MED | S.2209/H.R.4128-Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021 | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2022-04-14T18:31:12-04:00 | |
| 2774781 | FAEGRE DRINKER BIDDLE & REATH LLP 4cd47678-deec-4373-8cc1-9c1c9fd25dd5 | 1T | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | DRUGS FOR NEGLECTED DISEASES INITIATIVE OF NORTH AMERICA | 2022 | first_quarter | MED | Issues related to neglected diseases research and development, access, and drug pricing; COVID treatments research and development. | 0 | 1 | 2022-04-15T09:08:06-04:00 | |||
| 2774807 | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER fcee4152-0716-4b1a-bb86-796730c86dfd | Q1 | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER | 312496 | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER | 2022 | first_quarter | MED | CHGME, NIH, PACT ACT, Genomics, Cures 2.0, ARP | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office | 34560 | 0 | 0 | 2022-04-15T09:18:52-04:00 | |
| 2775052 | STANFORD UNIVERSITY 31e5dda3-918d-4907-a4e2-1b552d07a9c1 | Q1 | STANFORD UNIVERSITY | 36492 | STANFORD UNIVERSITY | 2022 | first_quarter | MED | H.R.708; S.168 Temporary Reciprocity to Ensure Access to Treatment Act H.R. 2256, S. 834 Resident Physician Shortage Reduction Act of 2021 Title VII HRSA Health Professions programs | HOUSE OF REPRESENTATIVES,SENATE | 90000 | 0 | 0 | 2022-04-15T11:33:40-04:00 | |
| 2775501 | WASHINGTON UNIVERSITY IN ST. LOUIS b68efb52-5a30-4d38-ad16-f15670459022 | Q1 | WASHINGTON UNIVERSITY IN ST. LOUIS | 40031264 | WASHINGTON UNIVERSITY IN ST LOUIS | 2022 | first_quarter | MED | General advocacy for NIH and other biomedical research. General advocacy supporting the continued responsible utilization of research animals. General support for the development of fair and effective organ transplant policies. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2022-04-15T14:05:13-04:00 | |
| 2775660 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 8689d831-c5bc-4eac-be70-b1f365692861 | Q1 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | ADVANCED MEDICAL TECHNOLOGY ASSOCIATION | 2022 | first_quarter | MED | Congressional outreach related to health care issues. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2022-04-15T15:18:33-04:00 | |
| 2775761 | THE CORMAC GROUP, LLC 6b5c121f-a4ed-44be-a0c6-9981f9fe472a | Q1 | THE CORMAC GROUP, LLC | 66773 | KESSLER FOUNDATION | 2022 | first_quarter | MED | Appropriations, DOD, TBI Research, Veterans Issues | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2022-04-15T16:12:40-04:00 | |
| 2775784 | O'NEILL AND ASSOCIATES 4c87f995-b834-489f-a6be-3054f2010307 | Q1 | O'NEILL AND ASSOCIATES | 73134 | POINT32HEALTH SERVICES, INC. (FORMERLY TUFTS HEALTH PLAN) | 2022 | first_quarter | MED | healthcare, medical | HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 0 | 2022-04-15T16:19:38-04:00 | |
| 2776001 | FORBES-TATE 45d560d5-0e70-4652-9624-4d6204098667 | Q1 | FORBES-TATE | 400976792 | AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION | 2022 | first_quarter | MED | Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2022-04-15T18:04:05-04:00 | |
| 2776029 | FORBES-TATE 28cbeef6-57ba-434a-971a-9a881d6041bb | Q1 | FORBES-TATE | 400976792 | AMGEN USA, INC. | 2022 | first_quarter | MED | Issues related to Biosimilars. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2022-04-15T18:27:50-04:00 | |
| 2776099 | FORBES-TATE aa9540ac-048f-419f-b039-3ab692de7d8f | Q1 | FORBES-TATE | 400976792 | CALIFORNIA LIFE SCIENCES ASSOCIATION | 2022 | first_quarter | MED | Issues related to the life sciences industry; Issues related to drug pricing and international reference pricing. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2022-04-15T20:01:24-04:00 | |
| 2776129 | FORBES-TATE 59b8d1a2-6f93-4f4c-b8f7-e1ea200fcf69 | Q1 | FORBES-TATE | 400976792 | COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION | 2022 | first_quarter | MED | Issues pertaining to government-wide federal regulation of cannabis. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2022-04-15T20:36:57-04:00 | |
| 2776135 | FORBES-TATE 2768fb45-274e-46c1-9a96-1406b5161e2e | Q1 | FORBES-TATE | 400976792 | CSL BEHRING | 2022 | first_quarter | MED | Issues related to COVID-19 response efforts. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2022-04-15T21:07:18-04:00 | |
| 2776523 | FOLEY & LARDNER LLP 82c7a5ec-3aea-4ba9-926a-13df9491c5d9 | Q1 | FOLEY & LARDNER LLP | 15042 | CARDIAC RMS | 2022 | first_quarter | MED | Remote Cardiac Monitoring | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2022-04-16T14:13:48-04:00 | |
| 2776538 | K&L GATES, LLP 485ba042-543a-4e6a-8d37-8f36c946b029 | Q1 | K&L GATES, LLP | 32098 | CHEMBIO DIAGNOSTICS, INC. | 2022 | first_quarter | MED | Issues related to disease diagnostics testing and manufacturing - no specific legislation. | Health & Human Services, Dept of (HHS) | 10000 | 0 | 0 | 2022-04-16T14:22:05-04:00 | |
| 2776598 | CAPITOL COUNSEL LLC e5f4d2b6-40a4-4874-9311-8e9b63462e39 | Q1 | CAPITOL COUNSEL LLC | 313715 | BLUE EARTH DIAGNOSTICS, INC. | 2022 | first_quarter | MED | To gain support for adequate Medicare reimbursement for diagnostic radiopharmaceuticals; Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2022-04-16T15:31:30-04:00 | |
| 2776626 | CAPITOL COUNSEL LLC 7a01cb6c-473d-4283-9906-89f4108d14fa | Q1 | CAPITOL COUNSEL LLC | 313715 | EMD SERONO, INC. | 2022 | first_quarter | MED | Monitoring and engaging on health policy proposals coming before the House of Representatives and the Administration pertaining to the availability and pricing of prescription drugs. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2022-04-16T16:01:12-04:00 | |
| 2776663 | CAPITOL COUNSEL LLC 8dbc3d08-93e6-476f-9df2-462ab90db6dd | Q1 | CAPITOL COUNSEL LLC | 313715 | MASSACHUSETTS BIOTECHNOLOGY COUNCIL | 2022 | first_quarter | MED | Monitor health and tax legislation pertaining to the biotechnology industry. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2022-04-16T16:18:47-04:00 | |
| 2776844 | FOLEY & LARDNER LLP e193a3c7-cdf1-42a9-bfda-2cc0f62d9537 | Q1 | FOLEY & LARDNER LLP | 15042 | RHYTHM MANAGEMENT GROUP | 2022 | first_quarter | MED | Remote Cardiac Monitoring | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2022-04-16T22:11:15-04:00 | |
| 2776861 | FOLEY & LARDNER LLP 8a94a480-2a11-432d-93b7-3c44ba68b1f8 | Q1 | FOLEY & LARDNER LLP | 15042 | VECTOR REMOTE CARE | 2022 | first_quarter | MED | Remote Cardiac Monitoring | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2022-04-16T22:37:05-04:00 | |
| 2776967 | AMERICAN SOCIETY OF ADDICTION MEDICINE a538f628-93d4-49e7-9496-79aed89551dc | Q1 | AMERICAN SOCIETY OF ADDICTION MEDICINE | 401104864 | AMERICAN SOCIETY OF ADDICTION MEDICINE | 2022 | first_quarter | MED | Advocated for Increased appropriations for HRSAs Substance Use Disorder Treatment and Recovery Loan Repayment Program. This program provides student loan repayment for addiction treatment professionals who commit to working in underserved or high-risk communities. Advocated for increased appropriations for HRSAs Addiction Medicine Fellowship Program. This Program provides grants to institutions with training opportunities for fellows in addiction medicine and addiction psychiatry who have demonstrated interest in providing addiction treatment in underserved communities. Advocated for increased appropriations for HRSAs Integrated Substance Use Disorder Training Program. This program provides grants to expand the number of nurse practitioners, physician assistants, psychologists, and social workers trained to provide addiction and mental health services in underserved community-based settings that integrate primary care, mental health, and addiction services. Advocated for increased appropriations for federal initiatives that lead to a more diverse addiction treatment workforce, such as scholarships and loan repayment targeting underrepresented minority addiction medicine professionals, including SAMHSAs Minority Fellowship Program. Advocated for the alignment of coverage and payment policies in Medicare and Medicaid with evidence-based and nationally recognized addiction treatment and placement criteria and standards (e.g., The ASAM Criteria). This would include permanent modification to the Institutions for Mental Diseases (IMD) exclusion to allow federal Medicaid funds to serve individuals with SUDs in those residential and inpatient settings that are able to demonstrate that patient assessments, clinical services, level-of-care and length-of-stay recommendations are consistent with The ASAM Criteria and that evidence based medication management using Food and Drug Administration (FDA)-approved medications are available to patients in such settings. Advocated for regulatory/sub-regulatory/application guidance th… | Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA) | 90000 | 0 | 0 | 2022-04-17T10:29:17-04:00 | |
| 2777194 | CLARK STREET ASSOCIATES 83f2fad4-db8d-4a6c-990b-180b8856e8c7 | Q1 | CLARK STREET ASSOCIATES | 401105692 | QORVO | 2022 | first_quarter | MED | Issues related to COVID testing including National Defense Authorization Act for FY 2023 (not yet introduced). | Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 180000 | 0 | 0 | 2022-04-17T13:16:04-04:00 | |
| 2777596 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 9bd7417b-a541-4c94-a2f1-f905ac53e70c | Q1 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | CHILDREN'S NATIONAL MEDICAL CENTER | 2022 | first_quarter | MED | Representation on health-related issues including reimbursement, research, public-health & clinical care | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 50000 | 0 | 0 | 2022-04-17T21:49:00-04:00 | |
| 2777623 | CORNERSTONE GOVERNMENT AFFAIRS, INC. b8b62dcc-9035-41c2-9e26-0c1460ff2544 | Q1 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | CITY OF HOPE MEDICAL CENTER | 2022 | first_quarter | MED | Medicare/Medicaid reimbursement, clinical research | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2022-04-17T22:17:15-04:00 | |
| 2777676 | MICHAEL N. MCCARTY LAW OFFICE PLLC 7f459b1d-24d6-44df-b2cc-f7b7819fbb89 | Q1 | MICHAEL N. MCCARTY LAW OFFICE PLLC | 401104300 | AMERICAN MEDICAL TECHNOLOGISTS | 2022 | first_quarter | MED | Support funding for the Centers for Disease Control & Prevention (CDC) Advanced Molecular Detection (AMD) program; support funding for CDC's Environmental Health Laboratory to (1) generate pediatric reference intervals for clinical diagnostic testing on children and (2) harmonize clinical laboratory test results across different testing platforms; legislation establishing a regulatory framework for laboratory-developed tests (LDTs), including S. 1666, S. 2209, and H.R. 4128. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2022-04-18T01:08:31-04:00 | |
| 2777691 | MARSHALL & POPP, LLC b654b8fe-adde-444d-a230-bb32d6579364 | Q1 | MARSHALL & POPP, LLC | 401105121 | BUTTERFLY NETWORK, INC. | 2022 | first_quarter | MED | Issues related to medical device manufacturing / insurance / technology, including S.3799, the PREVENT Pandemics Act. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2022-04-18T06:45:44-04:00 | |
| 2777724 | IMPACT MANAGEMENT GROUP 6de2b5c2-a5b4-4f09-904a-08d98cc4d0c0 | Q1 | IMPACT MANAGEMENT GROUP | 401104137 | CENTRAL ARKANSAS RADIATION THERAPY INSTITUTE, INC. | 2022 | first_quarter | MED | Supporting the passage of H.R. 3173 - Improving Seniors' Timely Access to Care Act of 2021 | HOUSE OF REPRESENTATIVES | 0 | 0 | 2022-04-18T08:24:33-04:00 | ||
| 2777840 | MANATOS & MANATOS d34e649c-cab5-47d3-91ac-20acd2ca437d | Q1 | MANATOS & MANATOS | 23634 | BARBARA ANN KARMANOS CANCER INSTITUTE | 2022 | first_quarter | MED | PPS-exemption | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2022-04-18T09:31:06-04:00 | ||
| 2778059 | TIBER CREEK GROUP cdde247e-a5e2-4d1b-ada5-d875a321db65 | Q1 | TIBER CREEK GROUP | 20744 | JAZZ PHARMACEUTICALS | 2022 | first_quarter | MED | Issues related to the FDA and S. 3032 - the FDA STATES Act (115th Congress), and Health and Human Services pertaining to CBD policies. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2022-04-18T10:42:43-04:00 | |
| 2778458 | AMERICAN ASSOCIATION OF ORTHOPAEDIC SURGEONS bd7fe340-684b-48b2-b28a-6fb519e0fff4 | Q1 | AMERICAN ASSOCIATION OF ORTHOPAEDIC SURGEONS | 52105 | AMERICAN ASSOCIATION OF ORTHOPAEDIC SURGEONS | 2022 | first_quarter | MED | Support appropriations for the Peer-Reviewed Orthopaedic Research Program (PRORP). PRORP is a competitive grant program that funds research pertaining to extremity war injuries. Support Research through support of HR 869/S289 Research Investment to Spark the Economy (RISE) Act | HOUSE OF REPRESENTATIVES,SENATE | 353803 | 0 | 0 | 2022-04-18T11:59:33-04:00 | |
| 2778510 | UNIVERSITY OF IOWA f317819a-7343-4d29-b261-db5cf36abf1f | Q1 | UNIVERSITY OF IOWA | 49191 | UNIVERSITY OF IOWA | 2022 | first_quarter | MED | Support for robust funding for federal agencies that fund medical and disease research | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2022-04-18T12:08:43-04:00 | |
| 2778572 | SQUIRE PATTON BOGGS 1abcc167-866e-4a9b-bfed-69435f39765c | Q1 | SQUIRE PATTON BOGGS | 30906 | ALLIANCE FOR BIOSECURITY | 2022 | first_quarter | MED | Preparedness and response as it relates to Biosecurity. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 100000 | 0 | 0 | 2022-04-18T12:20:11-04:00 | |
| 2779051 | RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) 5b8ed434-308a-456f-b6ea-8317485e0fba | Q1 | RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) | 400361684 | PPLA | 2022 | first_quarter | MED | Pharmaceutical Labeling | Food & Drug Administration (FDA) | 18700 | 0 | 0 | 2022-04-18T13:28:42-04:00 | |
| 2779456 | BLUEBIRD STRATEGIES e8a0feb4-1146-42fc-b677-183629a0637c | Q1 | BLUEBIRD STRATEGIES | 401105447 | MYOTONIC | 2022 | first_quarter | MED | Increasing funding for Myotonic Dystrophy research. Fiscal Year 2023 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2022-04-18T14:42:28-04:00 | ||
| 2779469 | BLUEBIRD STRATEGIES c9c5a4b1-4356-4b9d-9d97-b0db24c1bce4 | Q1 | BLUEBIRD STRATEGIES | 401105447 | MYRIAD GENETICS, INC. | 2022 | first_quarter | MED | Legislation to regulate clinical labs under CLIA and FDA. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2022-04-18T14:45:28-04:00 | |
| 2779931 | POWERS PYLES SUTTER & VERVILLE, P.C. 23c928ff-d008-4f9f-8b6f-ec09e308c9cd | Q1 | POWERS PYLES SUTTER & VERVILLE, P.C. | 32008 | GATEWAYS HOSPITAL & MENTAL HEALTH CENTER FOUNDATION | 2022 | first_quarter | MED | FY 2022 Consolidated Appropriations Act, H.R. 2471, now P.L. 117-103 American Rescue Plan Act of 2021, H.R. 1319, now P.L. 117-2 Infrastructure Investment and Jobs Act, H.R. 3684, now P.L. 117-58 Build Back Better Act, H.R. 5376 CONNECT for Health Act, S. 1512, H.R. 2903 FY 2023 House, Senate Departments of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bills FY 2023 House, Senate Department of Agriculture Appropriations Bills FY 2023 House, Senate Departments of Commerce and Justice, Science and Related Agencies Appropriations Bills FY 2023 House, Senate Financial Services and General Government Appropriations Bills FY 2023 House, Senate Department of Homeland Security Appropriations Bills FY 2023 House, Senate Departments of Transportation, Housing and Urban Development, and Related Agencies Appropriations Bills Pursuit of Grants with Federal Agencies House, Senate Comprehensive Addiction and Recovery Legislation House, Senate Legislation to Reform Behavioral Health and Substance Use Disorder Prevention and Treatment House, Senate Legislation to Fund FCC Broadband and Other Telehealth House, Senate Legislation to Train More Primary Care and Other Providers House Legislation to Implement Electronic Provider Consultations (E-Consults) with Related Telemedicine in Hospitals House, Senate Infrastructure Bills | Administration for Children & Families (ACF),Agency for Healthcare Research & Quality (AHRQ),Agriculture, Dept of (USDA),Bureau of Justice Assistance,Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Federal Communications Commission (FCC),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Justice, Dept of (DOJ),Office of Justice Program,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA) | 15000 | 0 | 0 | 2022-04-18T15:58:31-04:00 | |
| 2779952 | THE CONAFAY GROUP, LLC f0df2f30-12f8-498c-b54b-5e6057b2f874 | Q1 | THE CONAFAY GROUP, LLC | 401004840 | ACADIA PHARMACEUTICALS INC. | 2022 | first_quarter | MED | Pharmaceutical research/Medicare and Medicaid Reform | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2022-04-18T16:01:08-04:00 | |
| 2779997 | THE CONAFAY GROUP, LLC b03b8a11-1496-4fe1-9dbf-888da067dee8 | Q1 | THE CONAFAY GROUP, LLC | 401004840 | EMERGEX VACCINES HOLDING LTD. | 2022 | first_quarter | MED | Infectious disease, influenza and respiratory disease research | 0 | 0 | 2022-04-18T16:11:02-04:00 | |||
| 2780117 | POWERS PYLES SUTTER & VERVILLE, P.C. e3b2f6a3-7e73-4dd4-a1ad-33f0d7e8d3e5 | Q1 | POWERS PYLES SUTTER & VERVILLE, P.C. | 32008 | CORNERSTONE CARE, INC. | 2022 | first_quarter | MED | FY 2022 Consolidated Appropriations Act, H.R. 2471, now P.L. 117-103 American Rescue Plan Act of 2021, H.R. 1319, now P.L. 117-2 Infrastructure Investment and Jobs Act, H.R. 3684, now P.L. 117-58 Build Back Better Act, H.R. 537 CONNECT for Health Act, S. 1512, H.R. 2903 FY 2023 House, Senate Departments of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bills FY 2023 House, Senate Department of Agriculture Appropriations Bills FY 2023 House, Senate Departments of Commerce and Justice, Science and Related Agencies Appropriations Bills FY 2023 House, Senate Financial Services and General Government Appropriations Bills FY 2023 House, Senate Department of Homeland Security Appropriations Bills Pursuit of Grants with Federal Agencies House, Senate Comprehensive Addiction and Recovery Legislation House, Senate Legislation to Reform Behavioral Health and Substance Use Disorder Prevention and Treatment House, Senate Legislation to Fund FCC Broadband and Other Telehealth House, Senate Legislation to Train More Primary Care and Other Providers House Legislation to Implement Electronic Provider Consultations (E-Consults) with Related Telemedicine in Hospitals and Health Centers House, Senate Infrastructure Bills | Appalachian Regional Commission,Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Economic Development Administration,Federal Communications Commission (FCC),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA),Treasury, Dept of | 0 | 0 | 2022-04-18T16:28:48-04:00 | ||
| 2780128 | BRACEWELL LLP 47e2d871-7845-43da-b7c0-a08d3b4571f4 | Q1 | BRACEWELL LLP | 6837 | AIR LIQUIDE USA LLC | 2022 | first_quarter | MED | work related to medical gases | HOUSE OF REPRESENTATIVES,SENATE | 100000 | 0 | 0 | 2022-04-18T16:30:45-04:00 | |
| 2780159 | THE CONAFAY GROUP, LLC bd38f645-202a-4cf8-bf8f-006da81cea3e | Q1 | THE CONAFAY GROUP, LLC | 401004840 | SECURING AMERICAS MEDICINES AND SUPPLY SAMS | 2022 | first_quarter | MED | Strengthening the medical supply chain | Defense, Dept of (DOD),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2022-04-18T16:34:44-04:00 | ||
| 2780162 | IMPACT HEALTH POLICY PARTNERS b4bc9956-50a8-457e-b4f4-cb96882f09e1 | Q1 | IMPACT HEALTH POLICY PARTNERS | 401104696 | ABBOTT LABORATORIES | 2022 | first_quarter | MED | Issues related to coverage and reimbursement for durable medical equipment, medical devices, diagnostics and nutrition. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2022-04-18T16:34:51-04:00 | |
| 2780176 | IMPACT HEALTH POLICY PARTNERS 26f8da0c-b018-422c-9246-77c243ab2924 | Q1 | IMPACT HEALTH POLICY PARTNERS | 401104696 | CHILDREN'S HOSPITAL COLORADO | 2022 | first_quarter | MED | Issues related to pediatric research and children's hospital graduate medical education. H.R.6000, Cures 2.0 Act. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2022-04-18T16:36:14-04:00 | |
| 2780254 | IMPACT HEALTH POLICY PARTNERS 4a9c1e29-72c6-48d6-9ae0-f89ff5c54cc3 | Q1 | IMPACT HEALTH POLICY PARTNERS | 401104696 | HACKENSACK MERIDIAN HEALTH | 2022 | first_quarter | MED | Issues related to research funding, including ARPA-H, NIH, organ transplants, and other matters. H.R.6000, Cures 2.0 Act. | HOUSE OF REPRESENTATIVES,SENATE,White House Office | 40000 | 0 | 0 | 2022-04-18T16:40:48-04:00 | |
| 2780274 | THE CONAFAY GROUP, LLC 0f8a70e6-1748-4516-b956-312746d47efd | Q1 | THE CONAFAY GROUP, LLC | 401004840 | THE COALITION FOR THE ADVANCEMENT OF RESEARCH AND INNOVATION IN TRAUMA (CARIT) | 2022 | first_quarter | MED | Support for trauma research | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2022-04-18T16:43:49-04:00 | ||
| 2780364 | THE CONAFAY GROUP, LLC 307c0566-055b-4768-888a-3b44c94a4bf5 | Q1 | THE CONAFAY GROUP, LLC | 401004840 | ANI PHARMACEUTICALS | 2022 | first_quarter | MED | Support for medical research | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2022-04-18T16:55:17-04:00 | |
| 2780481 | THE CONAFAY GROUP, LLC 053405a2-0ece-40ce-bb93-668d3486caaa | Q1 | THE CONAFAY GROUP, LLC | 401004840 | CURIA GLOBAL, INC. (FORMERLY KNOWN AS ALBANY MOLECULAR RESEARCH, INC.) | 2022 | first_quarter | MED | Federal support to advance medical research | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2022-04-18T17:18:35-04:00 | |
| 2780627 | POWERS PYLES SUTTER & VERVILLE, P.C. 84cb4a1f-57e7-4ca3-84b1-94d60cb644d8 | Q1 | POWERS PYLES SUTTER & VERVILLE, P.C. | 32008 | PIH HEALTH FOUNDATION | 2022 | first_quarter | MED | FY 2022 Consolidated Appropriations Act, H.R. 2471, now P.L. 117-103 American Rescue Plan Act of 2021, H.R. 1319, now P.L. 117-2 Infrastructure Investment and Jobs Act, H.R. 3684, now P.L. 117-58 Build Back Better Act, H.R. 5376 CONNECT for Health Act, S. 1512, H.R. 2903 FY 2023 House, Senate Departments of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bills FY 2023 House, Senate Department of Agriculture Appropriations Bills FY 2023 House, Senate Departments of Commerce and Justice, Science and Related Agencies Appropriations Bills FY 2023 House, Senate Financial Services and General Government Appropriations Bills FY 2023 House, Senate Department of Homeland Security Appropriations Bills Pursuit of Grants with Federal Agencies House, Senate Legislation to Fund FCC Broadband and Other Telehealth House, Senate Legislation to Train More Primary Care and Other Providers House Legislation to Implement Electronic Provider Consultations (E-Consults) with Related Telemedicine in Hospitals House, Senate Infrastructure Bills | Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Federal Communications Commission (FCC),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA) | 30000 | 0 | 0 | 2022-04-18T18:02:04-04:00 | |
| 2780907 | THE RABEN GROUP 57b372bb-4c91-41ac-8b37-6823956f7c7d | Q1 | THE RABEN GROUP | 61458 | EXAGEN INC | 2022 | first_quarter | MED | Educate House and Senate members on the uses of a Lupus early diagnosis test | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2022-04-18T20:26:00-04:00 | |
| 2780997 | BLUESTONE STRATEGIES, LLC e2fd2423-ab42-40d5-bdc6-9078e20244d9 | Q1 | BLUESTONE STRATEGIES, LLC | 400658980 | VALYRIAN SMOKE LLC | 2022 | first_quarter | MED | Medical Research and Funding for Traumatic Brain Injury and Post-Traumatic Stress Disorder | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2022-04-18T21:14:10-04:00 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE lobbying_activities (
id INTEGER PRIMARY KEY,
filing_uuid TEXT NOT NULL,
filing_type TEXT NOT NULL,
registrant_name TEXT NOT NULL,
registrant_id INTEGER,
client_name TEXT NOT NULL,
filing_year INTEGER NOT NULL,
filing_period TEXT NOT NULL,
issue_code TEXT,
specific_issues TEXT,
government_entities TEXT,
income_amount INTEGER,
expense_amount INTEGER,
is_no_activity INTEGER DEFAULT 0,
is_termination INTEGER DEFAULT 0,
received_date TEXT,
CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
REFERENCES lobbying_filings_raw(filing_uuid)
);
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);